Wolfe Research Downgrades Vertex Pharmaceuticals to Peer Perform From Outperform

Published on 07/05/2025 at 10:31

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated Presents at American Diabetes Association 85th Scientific Sessions, Jun-20-2025 07:15 PM	07-15
Risk On Recharged	07-15
So, what about this inflation?	07-15
Vertex Pharmaceuticals Incorporated Announces Broad Reimbursement Agreement with NHS England for ALYFTREK®? an Innovative Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis	07-15	CI
Vertex announces broad reimbursement agreement with NHS England for Alyftrek for the treatment of cystic fibrosis	07-15	RE
JPMorgan Raises Price Target on Vertex Pharmaceuticals to $517 From $515	07-14	MT
RBC Raises Price Target on Vertex Pharmaceuticals to $430 From $420, Keeps Sector Perform Rating	07-07	MT
Vertex Says Long-Term Data Show Casgevy's 'Durable' Clinical Benefits in Blood Disorder Trials	07-03	MT
Vertex Pharmaceuticals Presents Longer-Term Data at the 2025 European Hematology Association Congress Demonstrating Durability of CASGEVY®? and Provides Update on Expanding Global Access to CASGEVY	07-03	CI
Vertex Pharmaceuticals Announces European Commission Approval of ALYFTREK, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis	07-01	CI
EU approves Vertex's next-generation cystic fibrosis drug	07-01	RE
EU approves Vertex's next-generation cystic fibrosis drug	07-01	RE
Vertex Pharmaceuticals Says European Commission Approves Alyftrek for Treating Cystic Fibrosis	07-01	MT
Vertex's next-generation cystic fibrosis drug gets EU approval	07-01	RE
AbbVie to buy Capstan for up to $2.1 billion in immunology push	06-30	RE
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell 1000 Dynamic Index	06-30	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Value-Defensive Index	06-30	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 3000E Value Index	06-30	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 3000 Value Index	06-30	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell Top 200 Value Index	06-30	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Value Index	06-30	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell Top 200 Value Benchmark	06-29	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 3000E Value Benchmark	06-29	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 3000 Value Benchmark	06-29	CI
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Value Benchmark	06-29	CI